p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma

European Urology

Volumn 41, Issue 2, 2002, Pages 182-189

  Rodríguez Alonso, Andrés ^a   Pita Fernández, Salvador ^b   González Carreró, Joaquin ^a   Luis Nogueira March, José ^a   Schmitz Drager B J ^c  

^a HOSPITAL XERAL CÍES   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c NONE

Author keywords

Bladder neoplasm; Ki67; P53; Prognosis; Stage T1; Survival

Indexed keywords

ALPHA2B INTERFERON; BCG VACCINE; DOXORUBICIN; KI 67 ANTIGEN; METHOTREXATE; MITOMYCIN C; MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGE; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME;

AGED; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SPAIN; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0036487680     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(01)00038-0     Document Type: Article

References (26)

1. Dinney CPN, Babkowski RC, Antelo M, Perrote P, Liebert M, Zhang HZ et al. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. J Urol 1998;160:1285-90.
2. Kiemeney LALM, Witjes JA, Hejbroek RP, Koper NP, Verbeek ALM, Debruyne FMJ et al. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Br J Urol 1994;73:164-71.
3. Martínez-Piñeiro JA, Martínez-Piñeiro L. Tumores vesicales. In: Jiménez Cruz JF, Rioja Sanz LA, editors. Tratado de Urología. Barcelona, JR Prous Editores, 1993. p. 1151-1204.
4. Witjes JA, Kiemeney LALM, Oosterhof GON, Debruyne FMJ. Prognostic factors in superficial bladder cancer. Eur Urol 1992;21: 89-97.
5. Mostofi FK, Sobin LH, Torlani H. Histological typing of urinary bladder tumors. In: International Histological Classification of Tumours, No 10. Geneva, World Health Organization, 1973.
6. Hermanek P, Hutter RVP, Sobin LH. TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours, Ed 4. Berlin, Springer, 1997. p. 263-326.
7. Lipponen PK. Review of cytometric methods in the assesment of prognosis in transitional cell bladder cancer. Eur Urol 1992;21:177-83.
8. Lipponen PK, Eskelinen MJ, Kiviranta J, Pesonen E. Prognosis of transitional cell bladder cancer: A multivariate prognostic score for improved prediction. J Urol 1991;146:1535-40.
9. Liukkonen T, Rajala P, Raitanen M, Rintala E, Kaasinen E, Lipponen P et al. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (stage pTa/T1) bladder cancer: A prospective comparative study. Eur Urol 1999;36: 393-400.
10. Lipponen P, Aaltomaa S, Eskelinen M, Ala-Opas M, Kosma VM. Expression of p21 (waf1/cip1) protein in transitional cell bladder tumours and its prognostic value. Eur Urol 1998;34:237-43.
11. Raitanen MP, Nieminen P, Tammela TLJ. Impact of tumour grade, stage, number and size, and smoking and sex, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder. Br J Urol 1995;76:470-4.
12. Zieger K, Wolf H, Olsen PR, Hojgaard K. Long-term survival of patients with bladder tumours: The significance of risk factors. Br J Urol 1998;82:667-72.
13. Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000;163: 73-8.
14. Hermann GG, Horn T, Steven K. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage TI transitional cell bladder cancer. J Urol 1998;159:91-4.
15. Lane DP. p53 and human cancers. Br Med Bull 1994;50(3):582-99.
16. Herr HW, Bajorin DF, Scher HI, Cordón-Cardo C, Reuter VE. Can p53 help select patients with invasive bladder cancer for bladder preservation? J Urol 1999;161:20-3.
17. Tsuji M, Kojima K, Murakami Y, Kanayama H, Kagawa S. Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: Immunohistochemical analysis of radical cystectomy specimens. Br J Urol 1997;79:367-72.
18. Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC et al. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 1998;58:1090-4.
19. Nakopoulou L, Constantinides C, Papandropoulos J, Theodoropoulos G, Tzonou A, Giannopoulos A et al. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: Comparison with DNA ploidy. Urology 1995;46:334-40.
20. Qureshi KN, Griffiths TRL, Robinson MC, Marsh C, Roberts JT, Hall RR et al. TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer. Clin Cancer Res 1999;5:3500-7.
21. Bernardini S, Adessi GL, Billerey C, Chezy E, Carbillet JP, Bittard H et al. Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas. J Urol 1999; 162:1496-501.
22. Linden MD, Nathanson SD, Zarbo RJ. Evaluation of anti-p53 antibody staining. Quality control and technical considerations. Appl Immunohistochem 1994;2(3):218-24.
23. Pfister C, Lacombe L, Vezina MC, Moore L, Larue H, Têtu B et al. Prognostic value of the proliferative index determined by ki-67 immunostaining in superficial bladder tumors. Hum Pathol 1999;11:1350-5.
24. Schmitz-Dräger BJ, Goebell P, Ebert T, Fradet Y. p53 immunohistochemistry as a prognostic marker in bladder cancer playground for urologic scientists? Eur Urol 2000;38:691-700,
25. Gontrero P, Casetta G, Zitella A, Ballario R, Pacchioni D, Magnani C, Muir GH, Tizzani A. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumor recurrence in superficial transitional cell carcinoma of the bladder. Eur Urol 2000;38:287-96.
26. Nocito A, Bubendorf L, Maria Tinner E, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T. Schoenenberger AJ, Flury R, Jager P, Luc Fehr J, Schrarml P, Moch H, Mihatsch MJ, Gasser T, Sauter GJ. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. Pathology 2000;194:349-57.